Crystal Pharma, S.A.U.
Crystal Pharma, S.A.U., headquartered in Spain, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality generic medicines. Founded in 2005, the company has established a strong presence across Europe and Latin America, focusing on therapeutic areas such as oncology, cardiology, and infectious diseases. With a commitment to innovation, Crystal Pharma offers a diverse portfolio of products that stand out for their efficacy and safety. The company has achieved significant milestones, including regulatory approvals that enhance its market position. Recognised for its dedication to quality and sustainability, Crystal Pharma continues to expand its reach, contributing to improved healthcare outcomes globally.
DitchCarbon Score
How does Crystal Pharma, S.A.U.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Crystal Pharma, S.A.U.'s score of 30 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Crystal Pharma, S.A.U.'s reported carbon emissions
Crystal Pharma, S.A.U., headquartered in Spain, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. In the pharmaceutical industry, companies are increasingly recognising the importance of addressing climate change and reducing carbon footprints. As such, Crystal Pharma may benefit from establishing clear emissions reduction targets and engaging in industry-standard climate initiatives to enhance its sustainability profile.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Crystal Pharma, S.A.U. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
